Johanne Kaplan - 18 Nov 2024 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Development Officer
Signature
/s/ Max A. Milbury, Attorney-in-Fact
Issuer symbol
PMN
Transactions as of
18 Nov 2024
Net transactions value
$0
Form type
4
Filing time
20 Nov 2024, 19:03:06 UTC
Previous filing
30 Oct 2023
Next filing
24 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +175,000 $0.000000 175,000 18 Nov 2024 Common Shares 175,000 $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest on November 18, 2025, and the balance shall vest ratably over 36 months.